Shahzad A - Search Results

1

Metabolomic Analysis of Nicotine-Induced Metabolic Disruptions and Their Amelioration by Resveratrol.

Iqbal H, Ilyas K, Rehman K, Aslam MA, Hussain A, Ibrahim M, Akash MSH, Shahid M, Shahzad A. Iqbal H, et al. Among authors: shahzad a. J Biochem Mol Toxicol. 2025 Jan;39(1):e70116. doi: 10.1002/jbt.70116. J Biochem Mol Toxicol. 2025. PMID: 39756060

2

Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C Virus.

Kamal S, Shahzad A, Rehman K, Tariq K, Akash MSH, Imran M, Assiri MA. Kamal S, et al. Among authors: shahzad a. Curr Med Chem. 2024;31(15):2052-2072. doi: 10.2174/0109298673234823230921090431. Curr Med Chem. 2024. PMID: 37855348

3

Modulation of Metabolic Pathways and Protection against Cadmium-Induced Disruptions with Taxifolin-Enriched Extract.

Khalid MF, Akash MSH, Rehman K, Shahzad A, Nadeem A. Khalid MF, et al. Among authors: shahzad a. ACS Omega. 2024 Jan 9;9(3):4057-4072. doi: 10.1021/acsomega.3c08989. eCollection 2024 Jan 23. ACS Omega. 2024. PMID: 38284084 Free PMC article.

4

Biochemical Investigation of Therapeutic Efficacy of Berberine-Enriched Extract in Streptozotocin-Induced Metabolic Impairment.

Akash MSH, Yaqoob S, Rehman K, Hussain A, Chauhdary Z, Nadeem A, Shahzad A, Shah MA, Panichayupakaranant P. Akash MSH, et al. Among authors: shahzad a. ACS Omega. 2024 Mar 22;9(13):15677-15688. doi: 10.1021/acsomega.4c00696. eCollection 2024 Apr 2. ACS Omega. 2024. PMID: 38585081 Free PMC article.

5

Biosynthesis and Multifaceted Characterization of Breynia nivosa-Derived Silver Nanoparticles: An Eco-Friendly Approach for Biomedical Applications.

Irshad K, Akash MSH, Rehman K, Nadeem A, Shahzad A. Irshad K, et al. Among authors: shahzad a. ACS Omega. 2024 Mar 20;9(13):15383-15400. doi: 10.1021/acsomega.3c10119. eCollection 2024 Apr 2. ACS Omega. 2024. PMID: 38585127 Free PMC article.

6

Biochemical investigation of FOXP3 genetic polymorphism and its association with biochemical parameters in pre-eclampsia patients.

Akash MSH, Victor F, Rehman K, Hussain A, Shahid M, Shahzad A. Akash MSH, et al. Among authors: shahzad a. Naunyn Schmiedebergs Arch Pharmacol. 2024 Nov 7. doi: 10.1007/s00210-024-03580-z. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 39508872

7

Flavonoids as modulators of metabolic reprogramming in renal cell carcinoma (Review).

Shahzad A, Liu W, Sun Y, Liu X, Xia J, Cui K, Sai B, Zhu Y, Yang Z, Zhang Q. Shahzad A, et al. Oncol Rep. 2024 Dec;52(6):167. doi: 10.3892/or.2024.8826. Epub 2024 Oct 18. Oncol Rep. 2024. PMID: 39422066 Free PMC article. Review.

8

The Mechanism of TRIM21 Inhibiting the Invasion and Migration of ccRCC by Stabilizing ASS1.

Yang Z, Cai J, Li J, Liu X, Liu W, Cui K, Bai Z, Dong Y, Peng D, Duan Q, Shahzad A, Zhang Q. Yang Z, et al. Among authors: shahzad a. Mol Carcinog. 2025 Feb;64(2):260-278. doi: 10.1002/mc.23840. Epub 2024 Nov 8. Mol Carcinog. 2025. PMID: 39513657

9

Advances in the impact of ASS1 dysregulation on metabolic reprogramming of tumor cells.

Xia J, Liu W, Ni Y, Shahzad A, Cui K, Xu Z, Zhang J, Wei Z, Teng Z, Yang Z, Zhang Q. Xia J, et al. Among authors: shahzad a. Cell Signal. 2025 Jan 6;127:111593. doi: 10.1016/j.cellsig.2025.111593. Online ahead of print. Cell Signal. 2025. PMID: 39778698

10

Innovative lipid nanoparticles: A cutting-edge approach for potential renal cell carcinoma therapeutics.

Shahzad A, Teng Z, Yameen M, Liu W, Cui K, Liu X, Sun Y, Duan Q, Xia J, Dong Y, Bai Z, Peng D, Zhang J, Xu Z, Pi J, Yang Z, Zhang Q. Shahzad A, et al. Biomed Pharmacother. 2024 Nov;180:117465. doi: 10.1016/j.biopha.2024.117465. Epub 2024 Sep 24. Biomed Pharmacother. 2024. PMID: 39321512 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters